Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
20,591
Total Claims
$2.7M
Drug Cost
591
Beneficiaries
$4,561
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+206%
Opioid rate vs peers
7.9% vs 2.6% avg
+327%
Cost per patient vs peers
$4,561 vs $1,068 avg
+107%
Brand preference vs peers
18.6% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid rate is 206% above Family Practice peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
7.9%
Opioid Rate
1,626
Opioid Claims
$39K
Opioid Cost
3.9%
Long-Acting Rate
Brand vs Generic
Brand: 3,809 claims · $2.3M
Generic: 16,629 claims · $364K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 463 | $487K |
| Tirzepatide | 181 | $202K |
| Fluticasone/Umeclidin/Vilanter | 241 | $168K |
| Apixaban | 223 | $158K |
| Dapagliflozin Propanediol | 154 | $150K |
| Semaglutide | 116 | $122K |
| Tiotropium Bromide | 139 | $81K |
| Budesonide/Formoterol Fumarate | 161 | $77K |
| Empagliflozin | 85 | $75K |
| Brexpiprazole | 53 | $62K |
| Budesonide/Glycopyr/Formoterol | 88 | $59K |
| Mirabegron | 102 | $46K |
| Linaclotide | 60 | $42K |
| Rivaroxaban | 40 | $39K |
| Insulin Aspart | 63 | $36K |
Prescribing Profile
Patient Profile
70
Avg Age
58%
Female
2.02
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data